TuHURA Biosciences (HURA) has been added to the Russell 3000 Index, with automatic inclusion in the Russell 2000 Index, as a part of the 2025 Russell indexes annual reconstitution. The company’s addition to the Russell 3000 Index and the Russell 2000 Index was effective as of market close, Friday, June 27th. Over $10T in assets are benchmarked against Russell’s U.S. Indexes, which are part of FTSE Russell, a global index provider wholly owned by London Stock Exchange Group (LDNXF).
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HURA:
- TuHURA Biosciences Completes Acquisition of Kineta, Inc.
- TuHURA Biosciences Increases Authorized Common Stock Shares
- Buy Rating for TuHURA Biosciences: Promising Phase 3 Study and Strategic Merger with Kineta Inc.
- TuHURA Biosciences initiates Phase 3 approval trial of IFx-2.0 in carcinoma
- TuHURA Biosciences Approves Merger and Share Increase